Tag: Portable Oxygen Concentrators

LONDON and PLANO, Texas – Belluscura has announced a possible acquisition and has made a change to its executive leadership.  Belluscura has reached an agreement with TMT Acquisitions, a London-based acquisition vehicle in the technology, media and telecommunications sector, on the key terms of a possible share-for-share offer for the company, in a deal that would be valued at EUR 6 million. Belluscura will use the deal, which includes a $100,000 break-up fee, to help grow its portable...

LONDON and PLANO, Texas – Belluscura has received approval from the Hong Kong Department of Health – Medical Device Division to distribute its X-PLOR portable oxygen concentrator. The company has already received its first purchase order from a Hong Kong distributor. "We are very excited to receive the approval and begin sales in Hong Kong,” said Bob Rauker, CEO of Belluscura. “I am very pleased with our operations, quality control and sales teams receiving approval ahead...

 GOLETA, Calif. – Inogen’s new strategy is taking longer than expected, says CEO Nabil Shabshab, resulting in “disappointing” financial results for the second quarter, especially for its direct-to-consumer sales channel.  The company reported $26.8 million in DTC sales for the quarter compared to $40.6 million for the same period last year.  “While we have made progress with the execution of our commercial strategy, we are disappointed with the performance...

GOLETA, Calif. – Inogen’s 10.2% decrease in total revenues for the first quarter of 2023 was impacted, in part, by HME provider customers tightening their belts, but the company is making progress winning them over with its value proposition, says CEO Nabil Shabshab.  The company reported sales revenue of $55.8 million for the first quarter of 2023 compared to $67.4 million for the same period in 2022, about a 17% decrease.  “There were some challenges in the business-to-business...

GOLETA, Calif. – Inogen has reported total revenue of $72.2 million for the first quarter of 2023, in line with company expectations, reflecting a 10.2% decrease compared to the same period last year. It reported a net loss of $20.3 million vs. a net loss of $14.21 million. Adjusted EBITDA was a loss of $11.8 million, slightly better than company expectations. “First quarter revenue was in line with our internal expectations. We remain confident that our focus on revenue growth and disciplined...

GOLETA, Calif. – Inogen is prioritizing its prescriber channel as it seeks to drive productivity and profitability, and transform itself into “a med tech company that has a global footprint and can go beyond COPD,” says CEO Nabil Shabshab.  Compared to the direct-to-consumer channel, which requires significant investments in advertising and a salesforce to generate and convert leads, the prescriber channel has a higher return on investment, he says.  “(The...

GOLETA, Calif. - Inogen reported total revenue increased 15.3% to $88.1 million in the fourth quarter of 2022 compared to the same period in 2021.  The company reported total revenue increased 5.4% to $377.2 million for the full year 2022.  “Despite the headwinds we faced in 2022, I am pleased with how our team successfully managed these challenges, while growing revenue and executing on our transformation,” said Nabil Shabshab, president and CEO. “We remain focused...

GOLETA, Cailf. – Two major factors contributed to Inogen’s 13.2% increase in revenue in the third quarter: The company remediated “the significant portion of its backlog,” and it made “excellent progress” with its prescriber strategy, says President and CEO Nabil Shabshab.    Shabshab declined to detail the size of the backlog of orders in its domestic business-to-business channel, but Inogen recorded $42.5 million in sales for the channel in the third...

GOLETA, Calif. – Inogen has reported total revenue of $105.4 million for the third quarter of 2022, a 13.2% increase compared to the same period last year.  Revenue increased primarily due to higher domestic business-to-business sales, as well as continued strength in the rental channel, partially offset by lower international business-to-business and direct-to-consumer sales  “I am pleased with the progress the team has made on our transformational journey,” said...

LONDON and PLANO, Texas – Belluscura is doubling down on the POC market with a new device that’s now shipping in the U.S. and a number of deals to distribute it and a TV campaign to market it.  The company first launched its X-PLOR device last year.  “We learned a few things from the introduction, then made some changes to improve sound level and output,” said Jim Clement, head of commercial strategy, who has previously worked for DeVilbiss and GCE Healthcare....